Daniel Sanchez-Masian

Mrs. Daniel Sanchez-Masian

VetCT
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2021 in Life
Verified
Journal Article
Open access
PDF file
TKThilo von Klopmann
Thilo von Klopmann
SASaija Ahonen
Saija Ahonen
IEIrene Espadas-Santiuste
Irene Espadas-Santiuste
KMKaspar Matiasek
Kaspar Matiasek
DSDaniel Sanchez-Masian
Daniel Sanchez-Masian
Clare RusbridgeClare Rusbridge
Clare Rusbridge
Canine Lafora disease is a recessively inherited, rapidly progressing neurodegenerative disease caused by the accumulation of abnormally constructed insoluble glycogen Lafora bodies in the brain and other tissues due to the loss of NHL repeat containing E3 ubiquitin protein ligase 1 (NHLRC1). Dogs have a dodecamer repeat sequence within the NHLRC1 gene, which is prone to unstable (dynamic) expansion and loss of function. Progressive signs of Lafora disease include hypnic jerks, reflex and spontaneous myoclonus, seizures, vision loss, ataxia and decreased cognitive function. We studied five dogs (one Chihuahua, two French Bulldogs, one Griffon Bruxellois, one mixed breed) with clinical signs associated with canine Lafora disease. Identification of polyglucosan bodies (Lafora bodies) in myocytes supported diagnosis in the French Bulldogs; muscle areas close to the myotendinous junction and the myofascial union segment had the highest yield of inclusions. Postmortem examination of one of the French Bulldogs revealed brain Lafora bodies. Genetic testing for the known canine NHLRC1 mutation confirmed the presence of a homozygous mutation associated with canine Lafora disease. Our results show that Lafora disease extends beyond previous known breeds to the French Bulldog, Griffon Bruxellois and even mixed-breed dogs, emphasizing the likely species-wide nature of this genetic problem. It also establishes these breeds as animal models for the devastating human disease. Genetic testing should be used when designing breeding strategies to determine the frequency of the NHLRC1 mutation in affected breeds. Lafora diseases should be suspected in any older dog presenting with myoclonus, hypnic jerks or photoconvulsions.

1 May 2021 in Genes
Verified
Journal Article
Open access
PDF file
MCMatthias Christen
Matthias Christen
NJNils Janzen
Nils Janzen
AFAnne Fraser
Anne Fraser
ASAdrian Sewell
Adrian Sewell
VJVidhya Jagannathan
Vidhya Jagannathan
DSDaniel Sanchez-Masian
Daniel Sanchez-Masian
A 7-month-old, spayed female, domestic longhair cat with L-2-hydroxyglutaric aciduria (L-2-HGA) was investigated. The aim of this study was to investigate the clinical signs, metabolic changes and underlying genetic defect. The owner of the cat reported a 4-month history of multiple paroxysmal seizure-like episodes, characterized by running around the house, often in circles, with abnormal behavior, bumping into obstacles, salivating and often urinating. The episodes were followed by a period of disorientation and inappetence. Neurological examination revealed an absent bilateral menace response. Routine blood work revealed mild microcytic anemia but biochemistry, ammonia, lactate and pre- and post-prandial bile acids were unremarkable. MRI of the brain identified multifocal, bilaterally symmetrical and T2-weighted hyperintensities within the prosencephalon, mesencephalon and metencephalon, primarily affecting the grey matter. Urinary organic acids identified highly increased levels of L-2-hydroxyglutaric acid. The cat was treated with the anticonvulsants levetiracetam and phenobarbitone and has been seizure-free for 16 months. We sequenced the genome of the affected cat and compared the data to 48 control genomes. L2HGDH, coding for L-2-hydroxyglutarate dehydrogenase, was investigated as the top functional candidate gene. This search revealed a single private protein-changing variant in the affected cat. The identified homozygous variant, XM_023255678.1:c.1301A>G, is predicted to result in an amino acid change in the L2HGDH protein, XP_023111446.1:p.His434Arg. The available clinical and biochemical data together with current knowledge about L2HGDH variants and their functional impact in humans and dogs allow us to classify the p.His434Arg variant as a causative variant for the observed neurological signs in this cat.

1 January 2018 in Journal of Feline Medicine and Surgery Open Reports
Verified
Journal Article
Open access
CWCrystal White
Crystal White
JMJeremy Mortier
Jeremy Mortier
RVRanieri Verin
Ranieri Verin
TMThomas William Maddox
Thomas William Maddox
RGRita Gonçalves
Rita Gonçalves
DSDaniel Sanchez-Masian
Daniel Sanchez-Masian
Case summary: A 2-year-old male domestic shorthair cat presented to the University of Liverpool Small Animal Teaching Hospital with a 2 week history of altered mentation, blindness and focal epileptic seizures. MRI examination revealed generalised cerebral and cerebellar atrophy, diffuse T2-weighted hyperintensity of the white matter and meningeal thickening. Neuronal ceroid lipofuscinosis was confirmed on post-mortem examination. Relevance and novel information: This is the first report of the MRI findings of neuronal ceroid lipofuscinosis in a cat.

1 September 2026 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
DPDakir Polidoro
Dakir Polidoro
SBSofie F.M. Bhatti
Sofie F.M. Bhatti
PSPatrick Santens
Patrick Santens
Paul J. J. MandigersPaul J. J. Mandigers
Paul J. J. Mandigers
Koen Maurits SantifortKoen Maurits Santifort
Koen Maurits Santifort
TLTheofanis Liatis
Theofanis Liatis
Background: Propriospinal myoclonus (PSM) is characterized by repetitive, brief jerks of the trunk, hips, and knees in humans and has not been reported in dogs. Hypothesis/Objectives: To describe phenotype, diagnostic findings, treatment, and outcomes in presumptive PSM in dogs. Animals: Twenty-seven dogs with presumptive PSM. Methods: Multicenter, retrospective study of dogs with myoclonus affecting the limbs and trunk without head involvement, identified through online calls for suspected cases. Results: Median age at onset was 9 months (range, 2-44 months). Propriospinal myoclonus involved pelvic limbs in all dogs, thoracic limbs in 14/27 (52%), and trunk in 9/27 (33%). Pelvic limb myoclonus was extensor in all dogs, whereas thoracic limb involvement was extensor in 12/27 (44%) and flexor in 3/27 (11%) dogs. Episodes were observed in a non-weight-bearing posture in all dogs, mainly lateral (25/27; 93%) and sternal (12/27; 44%) recumbency. Neurological examination was normal in all dogs. Abnormalities were not detected on magnetic resonance imaging of the spinal cord (4/6) or brain (6/6) in 5/6 dogs; in the remaining dog, findings were unrelated to the presumptive PSM. Follow-up information was available for 26/27 (96%) dogs. Sixteen dogs (59%) received no treatment, of which 9/16 (56%) showed spontaneous reduction in PSM frequency. Treatment with various antiseizure medications was started in 11/27 (41%) dogs, of which 5/11 (45%) improved. Conclusions and clinical importance: Presumptive PSM affected young dogs and is likely idiopathic. The condition is characterized by extensor myoclonus predominantly affecting pelvic limbs during recumbency, with preserved mentation. Spontaneous improvement seems common. Abstract Translated to Dutch/Flemish: Achtergrond: Propriospinale myoclonus (PSM) wordt bij mens gekenmerkt door repetitieve, schokbewegingen van de romp, heupen en knieën. Tot op heden is deze aandoening niet beschreven bij honden. Doelstelling; Het beschrijven van het fenotype, diagnostische bevindingen, behandeling en klinische uitkomst. Dieren: Zevenentwintig honden met vermoedelijke PSM. Methoden—Multicentrische retrospectieve studie bij honden met myoclonus waarbij de ledematen waren betrokken, geïdentificeerd via online meldingen van vermoedelijke gevallen. Resultaten: De mediane leeftijd bij aanvang van de symptomen bedroeg 9 maanden (spreiding: 2-44 maanden). Bij alle honden was PSM aanwezig in de achterpoten, bij 14/27 (52%) in de voorpoten en bij 9/27 (33%) in de romp. De myoclonus van de achterpoten was bij alle honden in extensie. Ter hoogte van de voorpoten was de myoclonus in extensie (12/27 (44%) en in flexie (3/27 (11%). De episoden traden voornamelijk op in zijligging (25/27; 93%) en sternale (12/27; 44%). Neurologisch onderzoek was bij alle honden normaal. Magnetische resonantiebeeldvorming van ruggenmerg (4/6) en hersenen (6/6) was bij 5/6 honden normaal. Follow-upinformatie was beschikbaar voor 26/27 (96%) honden. Zestien honden (59%) kregen geen behandeling, waarvan 9/16 (56%) een spontane afname van de frequentie van de PSM vertoonden. Bij 11/27 (41%) honden werd een behandeling met aanvalswerende medicijnen gestart, waarbij 5/11 (45%) een verbetering vertoonden. Conclusies en klinische relevantie: Vermoedelijke PSM lijkt voornamelijk voor te komen bij jonge honden en is waarschijnlijk idiopathisch. Het klinisch beeld wordt gekenmerkt door een myoclonus in extensie van voornamelijk de achterpoten tijdens het liggen. Een spontane verbetering lijkt vaak voor te komen.

1 July 2026 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
CHCristian Santos Hernández
Cristian Santos Hernández
IGInés Martínez García
Inés Martínez García
RGRodrigo Gutierrez-Quintana
Rodrigo Gutierrez-Quintana
Koen Maurits SantifortKoen Maurits Santifort
Koen Maurits Santifort
ASAnna Suñol
Anna Suñol
DSDaniel Sanchez-Masian
Daniel Sanchez-Masian
Background: Limited information is available regarding comparison between clinical outcomes and post-treatment imaging findings in cats with the neurologic form of feline infectious peritonitis (FIP). Hypothesis/Objective: Describe post-treatment imaging findings and clinical outcomes in cats with neurologic FIP treated with antiviral drugs. Animals: Nine cats with a presumptive diagnosis of neurologic FIP undergoing advanced imaging before and after antiviral treatment (GS-441524, remdesivir, or both). Methods: Medical records from 8 institutions were reviewed retrospectively (January 1, 2020 to December 31, 2024). Included cats had pre- and post-treatment magnetic resonance imaging (MRI) or computed tomography (CT) studies. Treatments consisted of GS-441524 (6/9), remdesivir (2/9), or both (1/9). All cats received corticosteroids. Follow-up imaging was performed at variable time points after completion of antiviral treatment. Results: Central vestibular disease was the most common neuroanatomical localization (6/9). Obstructive hydrocephalus was present in all cases on initial and follow-up imaging. Cerebrospinal fluid analysis, available in 4 cats, included pleocytosis (neutrophilic in 3/4; lymphocytic in 1/4). Complete clinical recovery occurred in 5/9 cats. Four of 9 had residual neurologic deficits and 2/9 experienced recurrence of neurologic signs. None showed complete resolution of imaging abnormalities. Imaging changes did not consistently reflect clinical outcomes. In 4/9 cats, progression of obstructive hydrocephalus was observed, including cases with clinical improvement. Conclusions and clinical importance: Clinical improvement is not always consistent with radiologic resolution in cats with neurologic FIP treated with antivirals. Post-treatment MRI findings, particularly persistent or worsening obstructive hydrocephalus, should be interpreted alongside clinical status rather than as a sole indicator of therapeutic response.